Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol LGMN contributors: mct - updated : 07-12-2013
HGNC name legumain
HGNC id 9472
Location 14q32.12      Physical location : 93.170.151 - 93.215.047
Synonym name
  • asparaginyl endopeptidase
  • protease, cysteine, 1 (legumain)
  • Synonym symbol(s) PRSC1, AEP, LGMN1
    EC.number 3.4.22.34
    DNA
    TYPE functioning gene
    STRUCTURE 44.90 kb     13 Exon(s)
    10 Kb 5' upstream gene genomic sequence study
    regulatory sequence Promoter
    Binding site
    text structure
  • a TP53-binding site in intron 1 of the human legumain gene
  • MAPPING cloned Y linked N status provisional
    RNA
    TRANSCRIPTS type messenger
    identificationnb exonstypebpproduct
    ProteinkDaAAspecific expressionYearPubmed
    14 - 2073 - 433 - -
    15 - 2191 - 433 - -
    EXPRESSION
    Type ubiquitous
       expressed in (based on citations)
    organ(s)
    SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
    blood / hematopoieticspleen   highly
    Cardiovascularheart   predominantly
    Digestiveliver    
    Endocrinepancreas    
    Nervousbrain    
    Reproductivemale systemprostate   
    Respiratorylung    
    Urinarykidney   predominantly
    tissue
    SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
    Muscularstriatumskeletal  
    cell lineage
    cell lines
    fluid/secretion
    at STAGE
    physiological period pregnancy
    Text predominantly in placenta
    PROTEIN
    PHYSICAL PROPERTIES
    STRUCTURE
    motifs/domains
    conjugated GlycoP
    HOMOLOGY
    interspecies homolog to Schistosoma japonicum hemoglobinase
    homolog to murine Lgmn
    homolog to C.elegans W04G3.5
    Homologene
    FAMILY
  • protease subfamily C, cysteine, peptidase family C13
  • asparaginyl endopeptidase family
  • CATEGORY enzyme
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,cytoplasm,organelle,lumen
    intracellular,cytoplasm,organelle,endosome
    intracellular,cytoplasm,organelle,lysosome
    intracellular,nucleus
    text
  • is thought to be located and processed towards its active form primarily in the endo-lysosomes
  • endo-lysosomal and nuclear localizations
  • basic FUNCTION
  • having a strict specificity for hydrolysis of asparaginyl bonds (asparagine endopeptidase)
  • can also cleave aspartyl bonds slowly, especially under acidic conditions
  • may play a functional role in atherogenesis
  • might contribute to the invasiveness and aggressiveness of prostate cancer
  • may be involved in the processing of proteins for MHC class II antigen presentation in the lysosomal/endosomal system
  • cysteine protease legumain is involved in several biological and pathological processes
  • asparaginyl endopeptidase highly expressed in tumors
  • CELLULAR PROCESS protein, degradation
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • can directly cleave TARDBP at seven sites, including N291 and N306
  • legumain (LGMN) expression and its enzyme activity are regulated by TP53
  • cell & other
    REGULATION
    inhibited by iodoacetamide,maleimides,ovocystatin and cystatin C
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    in response to hypoxic stress on mammary adenocarcinoma, colorectal cancer, proliferating endothelial cells, and tumor-associated macrophages (TAMs)
    tumoral     --over  
    correlates with increased cell migration and invasion of ovarian cancer cells
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
  • potential biomarker for treatment of ovarian cancer
  • Therapy target
    SystemTypeDisorderPubmed
    cancerreproductiveovary
    molecular target for treatment of ovarian cancer
    diabetetype 1 
    can serve as novel targets in diabetes mellitus genetic therapy
    ANIMAL & CELL MODELS